Envoy Medical, Inc.
COCH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $225 | $316 | $237 | $310 |
| % Growth | -28.8% | 33.3% | -23.5% | – |
| Cost of Goods Sold | $742 | $789 | $498 | $769 |
| Gross Profit | -$517 | -$473 | -$261 | -$459 |
| % Margin | -229.8% | -149.7% | -110.1% | -148.1% |
| R&D Expenses | $10,179 | $8,956 | $4,975 | $3,939 |
| G&A Expenses | $6,826 | $7,264 | $2,585 | $2,473 |
| SG&A Expenses | $8,560 | $8,930 | $3,470 | $2,473 |
| Sales & Mktg Exp. | $1,734 | $1,666 | $885 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $18,739 | $17,886 | $8,445 | $6,412 |
| Operating Income | -$19,256 | -$18,359 | -$8,706 | -$6,871 |
| % Margin | -8,558.2% | -5,809.8% | -3,673.4% | -2,216.5% |
| Other Income/Exp. Net | -$1,539 | -$11,563 | -$7,217 | -$1,804 |
| Pre-Tax Income | -$20,795 | -$29,922 | -$15,923 | -$8,675 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$20,795 | -$29,922 | -$15,923 | -$8,675 |
| % Margin | -9,242.2% | -9,469% | -6,718.6% | -2,798.4% |
| EPS | -1.49 | -2.54 | -1.57 | -1.05 |
| % Growth | 41.3% | -61.8% | -49.5% | – |
| EPS Diluted | -1.49 | -2.54 | -1.57 | -1.05 |
| Weighted Avg Shares Out | 18,790 | 12,553 | 10,154 | 10,154 |
| Weighted Avg Shares Out Dil | 18,790 | 12,553 | 10,154 | 10,154 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $38 |
| Interest Expense | $816 | $0 | $0 | $0 |
| Depreciation & Amortization | $173 | $133 | $75 | $71 |
| EBITDA | -$19,806 | -$29,789 | -$8,631 | -$6,800 |
| % Margin | -8,802.7% | -9,426.9% | -3,641.8% | -2,193.5% |